Subject: NSTC is soliciting applications for the "Artificial Intelligence-Enabled Accelerated Drug Development Project" in 2026. Applications are open from now until January 30, 2026 (internal deadline is [date]).

Instructions:
I. This project focuses on AI, combining cross-domain and cross-industry resources to promote innovative applications in drug development and strengthen the independent R&D capabilities of domestic academic research teams in AI drug development tools. Applicant institutions and project leaders should carefully read this project solicitation announcement (attached). Key points for application are summarized below:

(I) Applicant institutions must be recipients of NSTC special research projects. This project is a single, integrated research project; projects recommended for funding will be included in the NSTC research project count.

(II) The project execution period is expected to be from June 1, 2026 to May 31, 2020 (approved on an annual basis). (III) For the project category, please select "Special Topic - On-Demand Audit," for the project type "General Strategic Project," and for the research type, please select "Integrated." For the project affiliation, please select "Department of Life Sciences," for the department code "B90-Project," and for the sub-department code, please select "B90D004 - Artificial Intelligence-Driven Drug Development"; or "Department of Engineering," for the department code "E98-Project," and for the sub-department code, please select "E9882-Artificial Intelligence-Enabled Accelerated Drug Development Project - AI Software."

(IV) The project content format should follow the format of Forms CM03 and CM04 in the "Attachments" section at the bottom of the solicitation announcement webpage. Form CM03 should be no more than 50 pages.

II. Applications for projects that do not receive funding will not be accepted.